About
Respira Therapeutics is a clinical-stage company developing inhaled therapies targeting cardiopulmonary diseases such as pulmonary arterial hypertension, using advanced drug formulation and inhalation delivery technologies.
Explore Respira Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.